Cargando…

Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review

BACKGROUND: Molecular testing has been used for cytologically indeterminate thyroid nodules (Bethesda III and IV), where the risk of malignancy is 10–40%. However, to date, the role of molecular testing in cytologically suspicious or positive for malignancy (Bethesda V and VI) thyroid nodules has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hier, Jessica, Avior, Galit, Pusztaszeri, Marc, Krasner, Joshua R., Alyouha, Noura, Forest, Veronique-Isabelle, Hier, Michael P., Mlynarek, Alex, Richardson, Keith, Sadeghi, Nader, Tamilia, Michael, Payne, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082804/ https://www.ncbi.nlm.nih.gov/pubmed/33910629 http://dx.doi.org/10.1186/s40463-021-00500-6

Ejemplares similares

Molecular mutations as a possible factor for determining extent of thyroid surgery
por: Krasner, Joshua R., et al.
Publicado: (2019)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Thyroidectomy for Graves’ Disease Predicts Postoperative Neck Hematoma and Hypocalcemia: A North American cohort study
por: Mohtashami, Sadaf, et al.
Publicado: (2021)

Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
por: Hosseini, S., et al.
Publicado: (2016)

Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review
por: Bandargal, Saruchi, et al.
Publicado: (2023)

Preoperative prediction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: a Canadian single-Centre experience
por: Larouche, Vincent, et al.
Publicado: (2020)

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
por: Alohali, Sama, et al.
Publicado: (2023)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves’ disease patients: a retrospective matched cohort study
por: You, Eunice, et al.
Publicado: (2019)

BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
por: Silver, Jennifer A., et al.
Publicado: (2021)

EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles
por: Elsherbini, Noha, et al.
Publicado: (2022)

Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
por: Jozaghi, Yelda, et al.
Publicado: (2013)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
por: Turkdogan, Sena, et al.
Publicado: (2018)

The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
por: Jooya, Alborz, et al.
Publicado: (2016)

Completion thyroidectomy: predicting bilateral disease
por: Ibrahim, Badr, et al.
Publicado: (2015)

Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2022)

The McGill Thyroid Nodule Score’s (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review
por: Khalife, Sarah, et al.
Publicado: (2016)

The relationship between upper airway collapse and the severity of obstructive sleep apnea syndrome: a chart review
por: Schwartz, Russell N., et al.
Publicado: (2015)

3-phase dual-energy CT scan as a feasible salvage imaging modality for the identification of non-localizing parathyroid adenomas: a prospective study
por: Roskies, Michael, et al.
Publicado: (2015)

The T4/T3 quotient as a risk factor for differentiated thyroid cancer: a case control study
por: Sasson, Mark, et al.
Publicado: (2017)

Development and validation of the modified index of fragility in head and neck cancer surgery
por: Semsar-Kazerooni, Koorosh, et al.
Publicado: (2023)

Preoperative vocal cord paralysis and its association with malignant thyroid disease and other pathological features
por: Kay-Rivest, Emily, et al.
Publicado: (2015)

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature
por: Labourier, Emmanuel, et al.
Publicado: (2020)

Does the likelihood of malignancy in thyroid nodules with RAS mutations increase in direct proportion with the allele frequency percentage?
por: Hudson, Thomas J., et al.
Publicado: (2023)

The first Canadian experience with the Afirma® gene expression classifier test
por: Kay-Rivest, Emily, et al.
Publicado: (2017)

The Bethesda System for reporting cervical cytology
por: Pangarkar, Meena A.
Publicado: (2022)

The use of a modified abbé island flap to reconstruct primary lip defects of over 80 %
por: Filimon, Sabin, et al.
Publicado: (2016)

Postthyroidectomy Throat Pain and Swallowing: Do Proton Pump Inhibitors Make a Difference?
por: Zawawi, Faisal, et al.
Publicado: (2013)

Second edition of 'The Bethesda System for reporting cervical cytology' – atlas, website, and Bethesda interobserver reproducibility project
por: Nayar, Ritu, et al.
Publicado: (2004)

Local Failure Rate in Oropharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy Without High-dose Clinical Target Volume
por: Almarzouki, Hatim, et al.
Publicado: (2018)

Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy
por: Hier, Jessica, et al.
Publicado: (2021)

Historical Perspective: How the Discovery of HPV Virus Led to the Utilization of a Robot
por: Morand, Grégoire B., et al.
Publicado: (2022)

Intraoperative parathyroid hormone level in parathyroidectomy: which patients benefit from it?
por: Zawawi, Faisal, et al.
Publicado: (2013)

Above and Beyond Age: Prediction of Major Postoperative Adverse Events in Head and Neck Surgery
por: Mascarella, Marco A., et al.
Publicado: (2021)

A retrospective cohort study: do patients with graves’ disease need to be euthyroid prior to surgery?
por: Al Jassim, Abrar, et al.
Publicado: (2018)

Recurrent Oral Cancer: Current and Emerging Therapeutic Approaches
por: da Silva, Sabrina Daniela, et al.
Publicado: (2012)

The role of brachytherapy for margin control in oral tongue squamous cell carcinoma
por: Ianovski, Ilia, et al.
Publicado: (2020)

Diagnostic Thyroidectomy May Be Preferable in Patients With Suspicious Ultrasonography Features After Cytopathology Diagnosis of AUS/FLUS in the Bethesda System
por: Lee, Yong Sang, et al.
Publicado: (2015)

Co-Overexpression of TWIST1-CSF1 Is a Common Event in Metastatic Oral Cancer and Drives Biologically Aggressive Phenotype
por: da Silva, Sabrina Daniela, et al.
Publicado: (2021)

Framing Concerns about Body Image during Pre- and Post-Surgical Consultations for Head and Neck Cancer: A Qualitative Study of Patient–Physician Interactions
por: Cherba, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bqdq6832fdbers8k3mjpq7ncqn